• Home
  • Engineered SH3-Derived Sherpabodies Function as a Modular Platform for Targeted T-cell Immunotherapy.

Engineered SH3-Derived Sherpabodies Function as a Modular Platform for Targeted T-cell Immunotherapy.

Author List
Hernández-López RA, Kesti T, Mäkelä AR, Zhao Z, Yu W, Tonai Y, Monzo HJ, Kalander K, Leppä S, Ojala PM, Lim WA, Saksela K
Publication
Cancer research
Publication ID (Profile URL)
https://researcherprofiles.org/profile/613163465
Publication Year
2025
PubMed ID
40029291